ConductScience.org, home

Paper40757154

Revolutionizing rheumatoid arthritis therapy: the potential of lipid nanocarriers.

Alarcon JF and 8 others. RSC Adv, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Revolutionizing rheumatoid arthritis therapy: the potential of lipid nanocarriers. Papers, record 40757154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40757154

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Revolutionizing rheumatoid arthritis therapy: the potential of lipid nanocarriers.
PubMed
Journal
RSC Adv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.47, provisional
iCite
Revised in PubMed
2025-08-06
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alarcon JFJennifer Fernandez
2Karusan NRNisha Rata
3Presciutti CClara
4Miras JJonathan
5Magana JRJosé Rodrigo
6Guerra-Rebollo MMarta
7Borrós SSalvadorhttps://orcid.org/0000-0002-4003-0381
8Ahmad NNorainihttps://orcid.org/0000-0002-1174-4748
9Fornaguera CCristinahttps://orcid.org/0000-0002-7014-3213

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References113

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136312688Overview of Methotrexate Toxicity: A Comprehensive Literature Review.Cureus2022https://conductscience.org/library/papers/36312688PubMed
230700021Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery.Pharmaceutics2019https://conductscience.org/library/papers/30700021PubMed
327865609Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application.J Pharm Sci2017https://conductscience.org/library/papers/27865609PubMed
419132915IL-17 and Th17 Cells.Annu Rev Immunol2009https://conductscience.org/library/papers/19132915PubMed
59229573NSAIDs, gastrointestinal injury, and cytoprotection.Gastroenterol Clin North Am1996https://conductscience.org/library/papers/9229573PubMed
629600391Safety and Antioxidant Efficacy Profiles of Rutin-Loaded Ethosomes for Topical Application.AAPS PharmSciTech2018https://conductscience.org/library/papers/29600391PubMed
721665123Seronegative spondyloarthritis.Best Pract Res Clin Rheumatol2010https://conductscience.org/library/papers/21665123PubMed
830410704Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art.Nano Rev Exp2017https://conductscience.org/library/papers/30410704PubMed
920193005Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.Immunol Rev2010https://conductscience.org/library/papers/20193005PubMed
1027199229Ethosomes and Transfersomes: Principles, Perspectives and Practices.Curr Drug Deliv2017https://conductscience.org/library/papers/27199229PubMed
1126872084Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis.Clinics (Sao Paulo)2016https://conductscience.org/library/papers/26872084PubMed
1235735679Fabrication of Ethosomes Containing Tocopherol Acetate to Enhance Transdermal Permeation: In Vitro and Ex Vivo Characterizations.Gels2022https://conductscience.org/library/papers/35735679PubMed
1327571096Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes.Pharmaceutics2016https://conductscience.org/library/papers/27571096PubMed
1426924445Nanoemulsions: formation, properties and applications.Soft Matter2016https://conductscience.org/library/papers/26924445PubMed
1518654426Nanocarriers as an emerging platform for cancer therapy.Nat Nanotechnol2007https://conductscience.org/library/papers/18654426PubMed
1636499432Ex Vivo Evaluation of Ethosomes and Transethosomes Applied on Human Skin: A Comparative Study.Int J Mol Sci2022https://conductscience.org/library/papers/36499432PubMed
1712847701Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.Arthritis Rheum2003https://conductscience.org/library/papers/12847701PubMed
1828324579Nanoemulsion: an advanced mode of drug delivery system.3 Biotech2015https://conductscience.org/library/papers/28324579PubMed
1932066146Adverse Effects of Low-Dose Methotrexate: A Randomized Trial.Ann Intern Med2020https://conductscience.org/library/papers/32066146PubMed
2039560334Revolutionizing rheumatoid arthritis treatment with emerging cutaneous drug delivery systems: overcoming the challenges and paving the way forward.Nanoscale2024https://conductscience.org/library/papers/39560334PubMed

See all 113 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42942845The Application Potential and Future Challenges of Plant-Derived Exosome-like Nanoparticles in the Treatment of Liver Diseases.Pharmaceutics2026https://conductscience.org/library/papers/42942845PubMed
42768197Design and development of piperine-loaded polymeric micellar gel for the management of rheumatoid arthritis.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42768197PubMed
42544244Theranostic Nanoprobes for Rheumatoid Arthritis: From Inflammation Visualization to Guided Precision Therapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42544244PubMed
41978717Bridging Pharmacology and Nanotechnology: Mechanistic Insights into Traditional Chinese Medicine-Based Nanodelivery Systems for Rheumatoid Arthritis.Int J Nanomedicine2026https://conductscience.org/library/papers/41978717PubMed
41939210Advancing Arthritis Therapy: The Frontier of Targeted and Responsive Nanomedicine.Int J Nanomedicine2026https://conductscience.org/library/papers/41939210PubMed
41142242Nanotechnology-driven synergy in cardio-oncology: enhancing tumor suppression and reducing cardiotoxicity.Front Pharmacol2025https://conductscience.org/library/papers/41142242PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40757154

GET https://conductscience.org/api/papers/v1/40757154/references?page=2